首页 | 本学科首页   官方微博 | 高级检索  
检索        


Targeted Therapies for Ovarian Cancer
Institution:1. University College London Hospitals, London, UK;2. UCL Cancer Institute, London, UK;1. Clinic of Obstetrics and Gynecology, University of Milan Bicocca, San Gerardo Hospital, Monza, Italy;2. Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium;3. Department of Obstetrics and Gynaecology, VU University Medical Center, Amsterdam, The Netherlands;4. Department of Obstetrics and Gynaecology, University Hospitals Leuven, and Department of Reproduction and Regeneration, KU Leuven, Herestraat 49, 3000 Leuven, Belgium;5. Division of Gynecologic Oncology, University Hospitals Leuven, Belgium;6. Department of Obstetrics and Gynaecology, Cliniques Universitaires St. Luc, UCL, Brussels, Belgium;7. Center for Gynaecologic Oncology Amsterdam, Antoni van Leeuwenhoek – Netherlands Cancer Institute, Amsterdam, The Netherlands;1. Division of Gynecologic Oncology, European Institute of Oncology, Milan, Italy;2. Department of Surgical Sciences, Division of Gynecology and Obstetrics, University of Cagliari, Italy;1. Gynaecological Cancer Centre, Royal Hospital for Women, Randwick NSW 2031, Australia;2. School of Women''s and Children''s Health, University of New South Wales, Kensington NSW 2031, Australia
Abstract:
Keywords:targeted therapy  ovarian cancer  anti-angiogenesis  PARP inhibitor  immunotherapy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号